Mounjaro for weight loss is generally prescribed for adults with a BMI of 30 or above
The supplemental approval was granted based on data from the Phase III EMBARK trial, which studied Xtandi plus leuprolide, placebo plus leuprolide (a synthetic hormone regulator) and Xtandi as a monotherapy
Dose optimization is critical for achieving therapeutic benefit
Several large-scale trials, including the LEADER and SUSTAIN-6 studies, demonstrated reduced cardiovascular risk in patients at high baseline risk
That includes dosing and escalation/de-escalation schedules, how to do the actual injection, how to deal with travel and so much more
This level may help promote satiety during weight-loss maintenance, especially if you are strength-training